ASCENSION INVESTMENT MANAGEMENT
4600 Edmundson Road St.St. Louis, MO 63134
Website: ascension.org
Firm Size
- Assets Under Management (AUM):$17.9 Billion
- Employees:30
- Firm Type:Hedge Fund
Description
Ascension Investment Management (AIM) is a financial investment firm based in St. Louis, Missouri. With a focus on socially responsible investing, AIM provides investment management services to a diverse range of institutional clients, including healthcare systems, foundations, and other non-profit organizations. As a subsidiary of Ascension, one of the largest non-profit health systems in the United States, AIM aligns its investment strategies with the mission and values of its parent organization. The team at AIM believes in investing in companies that not only offer strong financial returns but also exhibit social and environmental responsibility. AIM follows a disciplined investment approach, combining traditional and alternative investment strategies to construct portfolios that meet the unique objectives and risk tolerance of each client. The firm’s investment strategies include public equity, fixed income, private equity, and real assets such as infrastructure and real estate. Furthermore, AIM integrates environmental, social, and governance (ESG) factors into its investment decision-making process. Recognizing the potential impact of ESG issues on long-term investment performance, the firm conducts thorough analysis of companies’ sustainability practices and evaluates their commitment to responsible business practices. By incorporating ESG considerations and emphasizing socially responsible investments, Ascension Investment Management aims to generate positive social and environmental outcomes alongside strong financial returns for its clients.Latest News
Powered by
Oct 03, 2023: Cortica Closes $40 Million Series D Extension Led by CVS Health Ventures, LRVHealth, and Other Strategic Investors, Bringing Round Total to $115 Million
Cortica, the United States' leading physician-led, whole-child, value-based autism services company, has raised $40 million in a Series D extension, bringing the total Series D round to $115 million . The extension was entirely strategic, led by CVS Health Ventures, in conjunction with LRVHealth, Ascension Investment Management (a subsidiary of Ascension), and the University of Wisconsin Foundation.